Personal Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,129
Closed -$302K 9
2022
Q1
$302K Hold
4,129
0.13% 62
2021
Q4
$257K Hold
4,129
0.11% 70
2021
Q3
$244K Hold
4,129
0.1% 72
2021
Q2
$276K Hold
4,129
0.11% 64
2021
Q1
$261K Hold
4,129
0.12% 62
2020
Q4
$256K Sell
4,129
-134
-3% -$8.24K 0.12% 56
2020
Q3
$257K Hold
4,263
0.13% 58
2020
Q2
$251K Sell
4,263
-39
-0.9% -$2.33K 0.14% 55
2020
Q1
$240K Hold
4,302
0.14% 53
2019
Q4
$276K Buy
4,302
+39
+0.9% +$2.23K 0.12% 55
2019
Q3
$216K Buy
4,263
+134
+3% +$6.3K 0.1% 61
2019
Q2
$187K Sell
4,129
-134
-3% -$6.24K 0.09% 61
2019
Q1
$203K Sell
4,263
-234
-5% -$11.7K 0.11% 57
2018
Q4
$234K Buy
+4,497
New +$242K 0.15% 32

Other funds holding BMY

Personal Wealth Partners's BMY Position: Q2 2022 in Review

Personal Wealth Partners sold out of Bristol-Myers Squibb (BMY) in Q2 2022, closing a stake of 4,129 shares — an estimated $302K sold.

Personal Wealth Partners first reported a position in BMY in Q4 2018 and held it in 14 quarters. The position peaked at $302K in Q1 2022. 2,537 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

  • Personal Wealth Partners reported no remaining Bristol-Myers Squibb position as of Q2 2022 after selling out during the quarter.
  • Personal Wealth Partners sold 4,129 Bristol-Myers Squibb shares in Q2 2022, an estimated $302K.
  • Personal Wealth Partners first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 14 quarters.
  • Personal Wealth Partners's Bristol-Myers Squibb position peaked at $302K in Q1 2022.
  • 2,537 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on Personal Wealth Partners's 13F filing for Q2 2022.